Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Learn Which Crypto Assets Are Considered Low Risk and how to compare safety factors. This intro helps you screen assets with prudent criteria.
27,883 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Alphabet and Amazon just posted strong Q1 results as AI infrastructure spending accelerates. This article weighs whic...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
A Medicare cost shock is hitting many retirees in 2026. This guide breaks down what happened, how it could affect you...
A blockbuster TSMC update is reshaping the AI chip market. Here are three stocks I’m buying after Taiwan’s announceme...
Considering your first rental property means weighing local comfort against the pull of ambitious markets. This guide...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
This deep-dive breaks down Saga's Q1 2026 earnings, what the results mean for guidance, and how investors can score 2...
Yields on the 10-year Treasury push toward a key 4.75% level as investors weigh dividend-growth strategies against hi...
FuelCell Energy led a broad pullback in the fuel-cell space, with Plug Power and Bloom Energy sliding as investors bo...
Meta Platforms trades near the $630s as investors weigh AI-driven capex against margin gains. A growing capital bill ...